Pancreatic Cancer News and Research

RSS

Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.

Globus to build new protected cancer research networks for enhancing data security

With a $4.7 million grant from the National Cancer Institute, the University of Chicago's Globus and leading cancer researchers at University of Chicago Medicine will build new protected cancer research networks that enable collaborations while keeping sensitive health data secure and private.

13 Oct 2017

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Salk Professor and HHMI Investigator Ronald Evans has been awarded $2.5 million by Stand Up 2 Cancer (SU2C) as part of a multi-institution team to conduct clinical studies to open up a new avenue for immunotherapy in the treatment of pancreatic cancer.

12 Oct 2017

Cholesterol byproduct acts on specific immune cells to facilitate breast cancer spread

High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link.

12 Oct 2017

Research finds higher rates of cancer in world's ‘better’ countries

The world's "better" countries, with greater access to healthcare, experience much higher rates of cancer incidence than the world's "worse off" countries, according to new research from the University of Adelaide.

11 Oct 2017

Researchers discover mutation that amplifies capabilities of tumor-suppressor protein

Cancer researchers have long hailed p53, a tumor-suppressor protein, for its ability to keep unruly cells from forming tumors. But for such a highly studied protein, p53 has hidden its tactics well.

9 Oct 2017

New research can help develop better chemotherapy treatments for pancreatic cancer

Tal Danino, a professor at the Data Science Institute, is conducting research that could help scientists combat the most lethal of cancers: pancreatic cancer.

6 Oct 2017

Bariatric surgery linked to reduced risk of cancer for severely obese patients

Severely obese patients who undergo bariatric surgery lower their risk of developing cancer by at least a third, according to a University of Cincinnati College of Medicine researcher leading a large retrospective cohort study of patients in the western United States.

5 Oct 2017

Rapid, sensitive genetic test successfully detects some aggressive types of pancreatic cancer

A genetic test developed at UPMC proved highly sensitive at determining which pancreatic cysts are most likely to be associated with one of the most aggressive types of pancreatic cancer, UPMC and University of Pittsburgh School of Medicine scientists reported in Gut, the journal of the British Society of Gastroenterology.

3 Oct 2017

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

The Cancer Prevention and Research Institute of Texas has awarded UT Southwestern researchers more than $34 million for cancer research and faculty recruitment, including support for programs in pancreatic cancer, lung cancer, breast cancer, and melanoma.

19 Sep 2017

Research shows how bacteria inactivate common drug used to treat cancers

To the reasons that chemotherapy sometimes does not work, we can now add one more: bacteria. In a study published today in Science, researchers describe findings that certain bacteria can be found inside human pancreatic tumors.

18 Sep 2017

Clinical trial evaluates key-hole and open surgery in pancreatic cancer patients

A randomized clinical trial has compared key-hole (laparoscopic) surgery and open surgery in pancreatic cancer patients undergoing pancreaticoduodenectomy, or the Whipple procedure.

14 Sep 2017

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

When trace elements rise to toxic levels, bad things happen. Patients suffering from Alzheimer's and Parkinson's disease harbor significantly higher levels of zinc and iron in their brains than healthy patients.

6 Sep 2017

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

For many years, oncologists have known that cancers can secrete complex molecules into the blood and that levels of these molecules can be easily measured. These so-called 'tumor markers' are traditionally associated with a single dominant cancer type, for example Prostate Specific Antigen (PSA) linked to prostate cancer, Carcinoembryonic antigen (CEA) to colorectal cancer, CA125 to ovarian cancer, CA19.9 to pancreatic cancer and CA27.29 to breast cancer.

6 Sep 2017

Pancreatic Cancer News and Research

Further Reading

Globus to build new protected cancer research networks for enhancing data security

Salk scientists receive $2.5 million funding to conduct pancreatic cancer clinical study

Cholesterol byproduct acts on specific immune cells to facilitate breast cancer spread

Research finds higher rates of cancer in world's ‘better’ countries

Researchers discover mutation that amplifies capabilities of tumor-suppressor protein

New research can help develop better chemotherapy treatments for pancreatic cancer

Bariatric surgery linked to reduced risk of cancer for severely obese patients

Rapid, sensitive genetic test successfully detects some aggressive types of pancreatic cancer

UTSW receives $34 million CPRIT award for cancer research and faculty recruitment

Research shows how bacteria inactivate common drug used to treat cancers

Clinical trial evaluates key-hole and open surgery in pancreatic cancer patients

Controlling zinc transporter levels could be effective plan to combat pancreatic cancer, other diseases

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

Combined DNA and protein 'liquid biopsy' more accurate in identifying early-stage pancreatic cancer

Smartphone app could be used to screen for pancreatic cancer

New app could lead to earlier detection of pancreatic cancer by snapping a smartphone selfie

SBP scientist receives DoD award to identify new and efficacious treatments for pancreatic cancer

New clinical trial to test cancer drug in patients with advanced solid tumors

Research suggests novel approach to treating deadly pancreatic cancer

New study identifies gene critical to pancreatic cancer cell growth

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News